Most Recent
Vehicle maker Isuzu can't shut down an $18 million suit by car alarm company Directed Electronics over a former employee’s alleged theft of trade secrets.
Novartis unit Sandoz is appealing a tribunal decision in favour of pharmaceutical company Lundbeck over a licence to sell a generic version of leading antidepressant Lexapro.
Bix Six firm Ashurst has dropped Care A2 as a client on the eve of trial in the dairy company's long-running battle to quash rival A2 Milk's trade marks.
Gaming giant Aristocrat has settled a suit brought against its former head of design, who admitted to copying a "substantial" number of documents containing the company's sensitive trade secrets.
Aristocrat has asked the High Court to rule once and for all on whether its popular Lightning Link game is patentable, after a differently comprised court was evenly split on the question.
IP Australia has rejected AFT Pharmaceuticals’ bid to patent a combination cold and flu medication, finding the invention was little more than putting three different medications “in a box”.
Aristocrat has sued competitor Light & Wonder and two former employees for allegedly using confidential information about its popular Dragon Link poker game to develop a competing product.
Fortescue has defeated a bid by its former CFO’s green iron start-up to set aside search orders that were said to have been secured “off the back of egregious material non-disclosure”.
US drug giant Eli Lilly cannot register a trade mark consisting of the word 'hair' preceded by the 'greater-than' symbol, despite winning registration in the UK, Switzerland and New Zealand.
The developer of the blockbuster horror video game Dead by Daylight has succeeded in revoking the trade mark of rival developer of a virtual sporting game.